Reports for EFAVIRENZ

Ingredient

EFAVIRENZ

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
AURO-EFAVIRENZ 600MG TABLET Resolved 2018-09-17 2018-10-10 61711
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-09-15 2023-11-13 204524
JAMP-EFAVIRENZ 600MG TABLET Resolved 2022-04-06 2022-07-20 158082
JAMP-EFAVIRENZ 600MG TABLET Actual shortage 2023-10-18 2024-02-06 207333
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424

Showing 1 to 10 of 17

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260
SUSTIVA 200MG 200MG CAPSULE Discontinued 2021-06-14 2023-04-01 140881
SUSTIVA 50MG 50MG CAPSULE Discontinued 2021-06-14 2023-04-01 140884
SUSTIVA TABLETS 600MG TABLET Discontinued 2021-06-14 2022-10-01 140887

Showing 1 to 4 of 4